ArticleTheranostics2019

Lgr5-mediated p53 Repression through PDCD5 leads to doxorubicin resistance in Hepatocellular Carcinoma.

Zhili Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.